Trial Profile
Peptide B27PD (Optiquel ) as Corticosteroid-sparing Therapy for Chronic Non-infectious Uveitis (BOOTS)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 31 May 2019
Price :
$35
*
At a glance
- Drugs B 27PD (Primary)
- Indications Uveitis
- Focus Proof of concept; Therapeutic Use
- Acronyms BOOTS
- 22 May 2014 New trial record